Skip to content

What Type of Antipsychotic is Sulpiride?: A Guide to Its Classification and Function

4 min read

Sulpiride, known by brand names such as Dogmatil, is a medication primarily classified as an atypical antipsychotic, belonging to the benzamide class of drugs. This classification distinguishes it from older typical antipsychotics by its unique and selective pharmacological profile, which influences its therapeutic effects and side-effect tendencies. However, its history and mechanism sometimes lead to confusion regarding its categorization, a nuance worth exploring.

Quick Summary

Sulpiride is an atypical antipsychotic of the benzamide class, functioning as a selective dopamine D2 receptor antagonist. Its unique mechanism provides both stimulating effects at low doses and potent antipsychotic action at higher doses, with a lower risk of extrapyramidal side effects than typical antipsychotics.

Key Points

  • Atypical Antipsychotic: Sulpiride is primarily classified as an atypical antipsychotic, belonging to the benzamide class, due to its selective dopaminergic action and lower incidence of extrapyramidal symptoms.

  • Dose-Dependent Action: The drug's mechanism varies with dosage; low doses can influence presynaptic dopamine autoreceptors, while high doses act as an antipsychotic by blocking postsynaptic D2 receptors.

  • Selective Dopamine Antagonist: Sulpiride's main mode of action is its selective antagonism of dopamine D2 and D3 receptors, with minimal effect on other neurotransmitter systems.

  • Lower EPS Risk: Compared to typical antipsychotics like haloperidol, sulpiride carries a lower risk of causing extrapyramidal symptoms (EPS), which contributes to its atypical classification.

  • High Prolactin Risk: A significant and common side effect of sulpiride is hyperprolactinemia (elevated prolactin levels), which can lead to hormonal side effects such as galactorrhea and menstrual irregularities.

  • Varied Clinical Uses: Beyond treating schizophrenia (both positive and negative symptoms), sulpiride is also used in some regions for depression, anxiety, vertigo, and Tourette's syndrome, reflecting its dose-dependent properties.

In This Article

The Atypical Classification of Sulpiride

While some older texts may mention sulpiride in the context of typical antipsychotics, modern pharmacology almost universally classifies it as an atypical antipsychotic. This designation reflects several key differences in its action and side-effect profile when compared to first-generation antipsychotics like haloperidol or chlorpromazine. Atypical antipsychotics are generally known for a lower incidence of extrapyramidal symptoms (EPS), such as muscle stiffness and tremors, which are common with typical antipsychotics. Sulpiride's unique selectivity for dopamine receptors contributes to this milder side-effect profile and its classification.

A Closer Look at its Pharmacology

At a fundamental level, sulpiride is a substituted benzamide. It works primarily as a selective antagonist of dopamine D2 and D3 receptors, and to a lesser extent, D4 receptors. Unlike many other atypical antipsychotics that also act on serotonin (5-HT) receptors, sulpiride's pharmacological focus is heavily centered on the dopamine system. This selective action is what allows for its varied effects based on dosage.

How Sulpiride Functions: A Dose-Dependent Mechanism

One of the most notable features of sulpiride is its dose-dependent effect, which allows it to be used for different therapeutic purposes. The drug's mechanism effectively changes depending on the concentration in the brain, offering a dual functionality that is distinct from many other antipsychotics.

Low-Dose Effects

At lower doses, sulpiride's primary action involves blocking presynaptic dopamine autoreceptors. This increases dopamine turnover and subsequently enhances dopamine transmission in certain brain regions. This increase in dopaminergic activity can lead to stimulating and antidepressant-like effects. Because of this, low-dose sulpiride is sometimes used to help manage:

  • Major depressive disorder
  • Dysthymia
  • Anxiety symptoms
  • Vertigo in some regions

High-Dose Effects

At higher doses, sulpiride blocks postsynaptic D2 receptors more effectively. This action decreases dopaminergic activity in the mesolimbic pathway, helping to manage positive symptoms of psychosis, such as hallucinations and delusions. This mechanism is crucial for its use in treating schizophrenia.

Clinical Uses and Therapeutic Applications

Beyond its core use in schizophrenia, sulpiride is utilized for a range of other conditions across different countries, though its availability and approved indications vary significantly (it is not approved in the United States, Canada, or Australia). Its application includes both positive and negative symptoms of schizophrenia, as well as several off-label uses.

Common indications include:

  • Schizophrenia: Management of both acute and chronic symptoms.
  • Major Depressive Disorder: Used in low doses, particularly in Japan, and sometimes as an adjunct therapy.
  • Tourette's Syndrome: Effective in managing tics.
  • Other behavioral disorders: Sometimes used for severe behavioral issues in children, autism spectrum disorder, and agitation.

Atypical vs. Typical Antipsychotics: Key Differences

The table below highlights the key differences between sulpiride (an atypical antipsychotic) and typical antipsychotics like haloperidol, based on their mechanisms and common side effects. While the classification system is complex, these points illustrate why sulpiride is grouped differently.

Feature Sulpiride (Atypical) Haloperidol (Typical) Risperidone (Atypical)
Drug Class Substituted Benzamide Butyrophenone Benzisoxazole derivative
Primary Mechanism Selective D2, D3 antagonism; dose-dependent effects High-affinity D2 receptor antagonism High D2 and 5-HT2A receptor antagonism
Receptor Profile High D2 selectivity; low affinity for other receptors (e.g., muscarinic) Broad D2 antagonism; some action on other receptors Broad D2 and 5-HT2A antagonism
Extrapyramidal Symptoms (EPS) Risk Low to moderate High, especially at higher doses Low to moderate, but dose-dependent
Hyperprolactinemia High risk due to D2 antagonism Moderate to high risk High risk
Metabolic Side Effects Low risk (e.g., weight gain) Low risk Moderate to high risk (weight gain, dyslipidemia)
Sedation Low Moderate to high Moderate to high

Side Effects and Safety Profile

Although sulpiride has a more favorable side-effect profile regarding extrapyramidal symptoms compared to older drugs, it is not without its risks. The most significant and common adverse effect is an increase in the hormone prolactin (hyperprolactinemia), which is a direct result of its dopamine antagonism. This can lead to specific side effects:

  • For women: Menstrual irregularities or amenorrhea (absence of periods), galactorrhea (abnormal milk production).
  • For men: Erectile dysfunction, decreased libido, and gynecomastia (breast enlargement).

Other common side effects include:

  • Weight gain
  • Drowsiness or dizziness
  • Constipation and dry mouth
  • Insomnia
  • Anxiety or restlessness

Rare but serious side effects can include Neuroleptic Malignant Syndrome (NMS), seizures, and potentially cardiotoxic effects like QT interval prolongation. As with any psychiatric medication, close medical supervision and monitoring are essential for safe and effective treatment.

Conclusion: The Place of Sulpiride in Modern Psychiatry

Sulpiride's classification as an atypical antipsychotic is a reflection of its nuanced pharmacological profile, most notably its selective dopamine D2 receptor antagonism and dose-dependent effects. Its ability to produce different effects at varying doses provides unique therapeutic versatility. While it offers a lower risk of extrapyramidal side effects than typical antipsychotics, its higher propensity for prolactin-related side effects requires careful consideration. Because of these distinct properties, sulpiride retains a specific and valuable role in psychiatry, particularly in countries where it is approved, offering an alternative for patients who may not tolerate other antipsychotic agents.

For more detailed information on sulpiride's mechanism, you can review the scientific literature on platforms like PubMed.

Disclaimer: This information is for general knowledge and should not be taken as medical advice. Consult with a healthcare professional before starting any new supplement regimen.

Frequently Asked Questions

Sulpiride is generally considered an atypical, or second-generation, antipsychotic. Its classification is based on its selective action on dopamine receptors and a more favorable side-effect profile, particularly a lower risk of extrapyramidal symptoms, compared to typical antipsychotics.

The primary mechanism of action for sulpiride is its selective antagonism of dopamine D2 and D3 receptors. This effect is dose-dependent: at low doses it can influence presynaptic receptors, while at high doses it blocks postsynaptic receptors to reduce psychosis symptoms.

Common side effects of sulpiride include elevated prolactin levels (hyperprolactinemia), weight gain, drowsiness, dizziness, constipation, and restlessness. The hormonal side effects from hyperprolactinemia, such as galactorrhea and menstrual changes, are particularly common.

No, sulpiride is not approved for use by the FDA and is not available in the United States. It is more commonly used in Europe, Asia, Central America, and South Africa.

Sulpiride is primarily used to treat schizophrenia. Depending on the country and dosage, it may also be prescribed to help manage major depressive disorder, anxiety, vertigo, and Tourette's syndrome.

At higher doses, sulpiride is effective against the positive symptoms of schizophrenia, such as hallucinations and delusions. Some evidence also suggests it may be beneficial for negative symptoms (e.g., apathy, withdrawal), especially when used at low to moderate doses.

The main difference lies in the risk of extrapyramidal symptoms (EPS). Sulpiride, like other atypicals, has a significantly lower incidence of EPS compared to typical antipsychotics. However, sulpiride has a higher risk of hyperprolactinemia than many other atypicals.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.